Literature DB >> 14101009

CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION.

G L KLERMAN, J J SCHILDKRAUT, L L HASENBUSH, M GREENBLATT, D G FRIEND.   

Abstract

Entities:  

Keywords:  DEPRESSION; DOPA; MONOAMINE OXIDASE INHIBITORS; PLACEBOS

Mesh：

Substances：

Year:  1963        PMID： 14101009     DOI： 10.1016/0022-3956(63)90004-9

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN： 0022-3956            Impact factor:   4.791


× No keyword cloud information.
  5 in total

1.  Effects of L-DOPA Monotherapy on Psychomotor Speed and [11C]Raclopride Binding in High-Risk Older Adults With Depression.

Authors:  Bret R Rutherford; Mark Slifstein; Chen Chen; Anissa Abi-Dargham; Patrick J Brown; Melanie W Wall; Nora Vanegas-Arroyave; Yaakov Stern; Veronika Bailey; Emily Valente; Steven P Roose
Journal:  Biol Psychiatry       Date:  2019-04-15       Impact factor: 13.382

Review 2.  [Biochemistry of depression].

Authors:  N Matussek
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

Review 3.  A unifying hypothesis on the biochemical basis of affective disorder.

Authors:  M M Singh
Journal:  Psychiatr Q       Date:  1970

4.  Amines and abnormal mood.

Authors:  W G Dewhurst
Journal:  Proc R Soc Med       Date:  1969-11

5.  [The effects of dopa on inhibited depressions].

Authors:  N Matussek; H Pohlmeier; E Rüther
Journal:  Klin Wochenschr       Date:  1966-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.